Viewing Study NCT02471404


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2025-12-28 @ 11:36 PM
Study NCT ID: NCT02471404
Status: COMPLETED
Last Update Posted: 2019-03-26
First Post: 2015-06-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
Sponsor: AstraZeneca
Organization: